McCall, P.; Adams, C.E.; Willder, J.M.; Bennett, L.; Qayyum, T.; Orange, C.; Underwood, M.A.; Edwards, J.
Androgen Receptor Phosphorylation at Serine 308 and Serine 791 Predicts Enhanced Survival in Castrate Resistant Prostate Cancer Patients. Int. J. Mol. Sci. 2013, 14, 16656-16671.
https://doi.org/10.3390/ijms140816656
AMA Style
McCall P, Adams CE, Willder JM, Bennett L, Qayyum T, Orange C, Underwood MA, Edwards J.
Androgen Receptor Phosphorylation at Serine 308 and Serine 791 Predicts Enhanced Survival in Castrate Resistant Prostate Cancer Patients. International Journal of Molecular Sciences. 2013; 14(8):16656-16671.
https://doi.org/10.3390/ijms140816656
Chicago/Turabian Style
McCall, Pamela, Claire E. Adams, Jennifer M. Willder, Lindsay Bennett, Tahir Qayyum, Clare Orange, Mark A. Underwood, and Joanne Edwards.
2013. "Androgen Receptor Phosphorylation at Serine 308 and Serine 791 Predicts Enhanced Survival in Castrate Resistant Prostate Cancer Patients" International Journal of Molecular Sciences 14, no. 8: 16656-16671.
https://doi.org/10.3390/ijms140816656
APA Style
McCall, P., Adams, C. E., Willder, J. M., Bennett, L., Qayyum, T., Orange, C., Underwood, M. A., & Edwards, J.
(2013). Androgen Receptor Phosphorylation at Serine 308 and Serine 791 Predicts Enhanced Survival in Castrate Resistant Prostate Cancer Patients. International Journal of Molecular Sciences, 14(8), 16656-16671.
https://doi.org/10.3390/ijms140816656